About Jeffrey Hval
Form D filings for STAQ Pharma from 2017 to 2024 list Jeffrey Hval as executive officer and director.
Jeffrey Hval first appears on SEC filings in 2017.
Experience
This experience comes from SEC filings. The years are when the filings name Jeffrey Hval in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jeffrey Hval works with at each company, as listed on that company's latest Form D.
STAQ Pharma, Inc. · Form D, Sep 16, 2024
SH
Scott Hawig
Director
MS
Mark Spiecker
Executive officer and director
CL
Carol Lewis
Director
CK
Chet Kaczor
Director
DS
Dan Seff
Director
BH
Brad Hauert
Director
JB
Joseph Bagan
Chief Executive Officer and director
PJ
Paul Jenny
Director